GCL
CERE

Glazer Capital LLC’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Glazer Capital LLC’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,000
Closed -$1.64M – 175
2024
Q2 		$1.64M Buy
+40,000
New +$1.64M 0.13% 91